The National Primary Health Care Development Agency (NPHCDA), has said that it planned to vaccinate approximately 109 million Nigerians that will be eligible for the COVID-19 vaccination over the course of 2 years.
The Executive Director, NPHCDA, Dr. Faisal Shuaib, made the disclosure at the Presidential Task Force (PTF) on COVID-19 briefing, on Monday, in Abuja.
“We remain in anticipation of about 57million doses of COVID-19 vaccines from the COVAX Facility and the AU. Working with the States, the Federal Government plans to vaccinate all eligible population from 18 years and above, including pregnant women.
“However, the decision to vaccinate any pregnant woman will be made in consultation with her healthcare provider. There will be considerations of whether she is at high risk of contracting Covid-19 or not.
Shuaib said that additionally, the Federal Government had received the commitment of 1,500,000 and 100,000 doses of AstraZeneca from MTN and Government of India respectively.
“These eligible populations have been identified using the World Health Organization(WHO), vaccine allocation framework and prioritization roadmap, as well as the disease burden data from the Nigeria Center for Disease Control (NCDC).
“They are: the frontline healthcare workers, support staff; including those that work in high risk areas such as point of entry workers, rapid response teams, contact tracing teams, COVID-19 vaccination teams and strategic leadership.
“People aged 50 years and above and People aged 18 – 49 years, with significant co-morbidities and additional at-risk groups,” he noted.
The NPHCDA boss added that In order to facilitate the implementation process, the Technical Working Group (TWG), had come up with a strategy of pre-registration and scheduling of the target population to avoid over-crowding at vaccination posts.
“We have come up with a strategy called the TEACH approach, which will harness all the benefits of traditional, electronic, assisted and concomitant house-to-house registration to optimize the use of innovative technology.